Moreover, it has been reported that RECQL4 expression is increased in CRC [21] and it exacerbates resistance to oxaliplatin in colon adenocarcinoma via the activation of the PI3K/AKT signaling pathway [22]. This evidence concerns the gene RECQL4 and colon adenocarcinoma.